# Hyperfractionated Intensity-modulated Radiotherapy (IMRT) Versus Conventional Fraction IMRT for Patients With Loco-regionally Recurrent Nasopharyngeal Carcinoma.

> **NCT02456506** · NA · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 142 (estimated)

## Conditions studied

- Nasopharyngeal Neoplasms
- Mortality
- Quality of Life
- Complications

## Interventions

- **RADIATION:** Hyperfractionated IMRT
- **RADIATION:** Conventional Fraction IMRT

## Key facts

- **NCT ID:** NCT02456506
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-06
- **Primary completion:** 2022-12
- **Final completion:** 2023-03
- **Target enrollment:** 142 (ESTIMATED)
- **Last updated:** 2020-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02456506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02456506, "Hyperfractionated Intensity-modulated Radiotherapy (IMRT) Versus Conventional Fraction IMRT for Patients With Loco-regionally Recurrent Nasopharyngeal Carcinoma.". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02456506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*